Melinta Therapeutics is a biopharmaceutical company founded by Sterling Professors at Yale University
Our mission is to apply Nobel Prize–winning science to develop new therapeutics in the global fight against drug-resistant pathogens.
We are the proud developers of BAXDELA, an important therapeutic milestone in the treatment of serious skin infections in adult patients.
Visit us at Melinta.com to learn more.
Melinta Therapeutics, Inc. - The Antibiotics Company
For additional information about BAXDELA, call Melinta Therapeutics at 1-844-MED-MLNT (1-844-633-6568) or contact the US Food and Drug Administration at 1-888-INFO-FDA (1-888-463-6332).